Bill & Melinda Gates Foundation 13F annual report
Bill & Melinda Gates Foundation is an investment fund managing more than $342 million ran by Connie Collingsworth. There are currently 10 companies in Mrs. Collingsworth’s portfolio. The largest investments include Curevac N V and Lumiradx Limited, together worth $217 million.
$342 million Assets Under Management (AUM)
As of 8th November 2021, Bill & Melinda Gates Foundation’s top holding is 3,134,780 shares of Curevac N V currently worth over $171 million and making up 50.1% of the portfolio value.
In addition, the fund holds 5,574,059 shares of Lumiradx Limited worth $46.1 million.
The third-largest holding is BioNTech SE worth $40.6 million and the next is Vir Biotechnology Inc worth $29.5 million, with 677,777 shares owned.
Currently, Bill & Melinda Gates Foundation's portfolio is worth at least $342 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation office and employees reside in Seattle, Washington. According to the last 13-F report filed with the SEC, Connie Collingsworth serves as the Chief Operating Officer and Chief Legal Officer at Bill & Melinda Gates Foundation.
Recent trades
In the most recent 13F filing, Bill & Melinda Gates Foundation revealed that it had opened a new position in
Lumiradx Limited and bought 5,574,059 shares worth $46.1 million.
On the other hand, Connie Collingsworth disclosed a decreased stake in BioNTech SE by 0.9%.
This leaves the value of the investment at $40.6 million and 148,674 shares.
One of the smaller hedge funds
The two most similar investment funds to Bill & Melinda Gates Foundation are Ack Asset Management and Kirr Marbach & Co in/. They manage $342 million and $341 million respectively.
Connie Collingsworth investment strategy
Bill & Melinda Gates Foundation’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Health Care — making up 23.1% of
the total portfolio value.
The fund focuses on investments in the United States as
30.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
10% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $16 billion.
The complete list of Bill & Melinda Gates Foundation trades based on 13F SEC filings
These positions were updated on November 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Curevac N V |
No change
3,134,780
|
$171,200,000 | 50.12% |
| Lumiradx Limited |
Opened
5,574,059
|
$46,100,000 | 13.50% |
| BioNTech SE |
85.69%
148,674
|
$40,600,000 | 11.89% |
| Vir Biotechnology Inc |
75.60%
677,777
|
$29,500,000 | 8.64% |
| Immuncore Hldgs Plc |
No change
576,923
|
$21,400,000 | 6.26% |
| Butterfly Network Inc |
No change
1,011,003
|
$10,600,000 | 3.10% |
| Atreca Inc |
No change
1,396,644
|
$8,700,000 | 2.55% |
| Sera Prognostics Inc |
Opened
779,814
|
$8,700,000 | 2.55% |
| Amyris Inc |
No change
292,398
|
$4,000,000 | 1.17% |
| Zymergen Inc |
No change
59,970
|
$800,000 | 0.23% |
| No transactions found | |||
| Showing first 500 out of 10 holdings | |||
Hedge funds similar to Bill & Melinda Gates Foundation
- Helikon Investments Ltd
- Belvedere Trading
- Adelphi Capital LL.P.
- Oak Harvest Investment Services
- Glovista Investments
- Blue Bell Private Wealth Management
- Private Portfolio Partners
- Ack Asset Management
- Kirr Marbach & Co in/
- Capco Asset Management
- Half Sky Capital (uk) Ltd
- Compton Capital Management Inc ri
- Integrated Investment Consultants
- Strategic Wealth Partners